Chantix Diabetes Side Effects
The use of Chantix has been associated with a number of adverse events consistent with new-onset diabetes. Lawsuits are being considered. >>REQUEST A CLAIM REVIEW
According to adverse drug event reports received by the FDA, there may be a connection between the use of Chantix and diabetes. The stop smoking drug has been linked with a number of reports involving loss of glycemic control, which includes new onset diabetes.
The Chantix attorneys at Saiontz & Kirk, P.A. are evaluating the potential for legal cases on behalf of individuals who were diagnosed with diabetes for the first time after using Chantix.
While studies have not firmly established that Chantix causes diabetes, sufficient reports of problems associated with the use of the drug warrant further investigation. Potential cases are being reviewed throughout the United States.
>>REVIEW A POTENTIAL CHANTIX DIABETES CASE <<
CHANTIX AND DIABETES
Chantix (generic varenicline tartrate) is a prescription drug sold to help people quit smoking. It was approved by the U.S. Food and Drug Administration in May 2006 and has become one of the fastest growing medications in the country.
Within the first two years the drug was on the market, concerns started to surface about a possible connection between Chantix and a variety of serious and potentially life threatening side effects. By late 2007, Chantix was one of the most frequently listed drugs associated with a wide variety of serious adverse event reports received by the FDA. This led an independent consumer watchdog group, The Institute for Safe Medication Practices, to conduct a detailed analysis of all reported problems associated with Chantix.
An examination of adverse event reports received by the FDA between May 2006 and December 2007 revealed at least 544 reports suggesting Chantix side effects may have caused a loss of glycemic control, including a number of cases that contained symptoms and lab tests consistent with onset of diabetes. This likely represents only a small portion of the true number of adverse events experienced by users, as it is generally accepted that only about 1% to 10% of all serious events are reported to the FDA.
While many of the reported adverse events in this category were a result of weight gain or weight loss, which could be expected among a population of people quitting smoking, a large number of the cases had classic indications of new onset diabetes mellitus from Chantix. This included reports of elevated blood glucose, hunger, thirst and frequent urination.
The study does not establish a firm causative link between Chantix and diabetes, but the reports do provide a compelling association which has raised concerns among experts, doctors and patients.
CHANTIX DIABETES LAWSUITS
The lawyers at Saiontz & Kirk, P.A. are reviewing potential cases of diabetes from Chantix to determine whether compensation may be available through a Chantix lawsuit. Cases are also being investigated for a variety of other problems linked to the medication, including an increased risk of suicides and abnormal behavior, as well as an association with an increased number of serious injuries from accidents and falls.
If you, a friend or family member were diagnosed with new onset diabetes after taking Chantix, request a free consultation to have a potential claim reviewed by our Chantix attorneys. The circumstances surrounding the diagnosis will be evaluated to determine if there may be a connection between Chantex and diabetes. There are no fees or expenses unless a recovery is obtained
